Study Group	Control Group	P value
	PT-Cy + ATLG	PT-Cy
	N = 21	N = 42
Median patient age at HSCT (range)	60 (24-71)	56 (22-77)	0.691
Median donor age at HSCT (range)	41 (18-68)	34 (18-70)	0.41
Gender
Female	N = 9	N = 16	0.71
Male	N = 12	N = 26
Disease type
ALL	N = 2	N = 6	0.974
AML	N = 13	N = 23
MPN/MDS	N = 4	N = 8
MM/Lymphoma	N = 2	N = 5
Disease status
CR1	N = 7	N = 13	1
CR > 1	N = 7	N = 13
Not in CR	N = 7	N = 16
Type of HSCT
MRD	N = 4	N = 7	0.881
MUD	N = 4	N = 12
MMUD	N = 4	N = 7
MMRD	N = 9	N = 16
Conditioning regimen$
MAC	N = 13	N = 30	0.567
RTC	N = 8	N = 12
Median CD3+ infused (106/kg)	464 (409-496)	399 (347-511)	0.197